Differences in the effect of antidepressants on sleep;Unterschiede in den wirkungen von antidepressiva auf den schlaf

Psychopharmakotherapie

Volumn 6, Issue 3, 1999, Pages 91-95

  Steiger, Axel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressants; Hormones; Prediction; Sleep

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROFAROMINE; CLOMIPRAMINE; DOXEPIN; GROWTH HORMONE; HYDROCORTISONE; IMIPRAMINE; LEVOPROTILINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORCLOMIPRAMINE; OXAPROTILINE; OXYMAPROTILINE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANYLCYPROMINE PLUS TRIFLUOPERAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNCLASSIFIED DRUG; VENLAFAXINE;

DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; POLYSOMNOGRAPHY; PROLACTIN RELEASE; PSYCHOPHARMACOTHERAPY; REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP STAGE;

EID: 0032808580     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995;18:6-11.
2. Billiard M. Narcolepsy. Clinical features and aetiology. Ann Clin Res 1985;17:220-6.
3. Chen CN. Sleep, depression and antidepressants. Br J Psychiatry 1979;135:385-402.
4. Dorsey CM, Lukas SE, Cunningham SL. Fluoxetine-induced sleep disturbance in depressed patients Neuropsychopharmacology 1996;14: 437-42.
5. Hendrickse WA, Roffwarg HP, Grannemann BD, Orsulak PJ, et al. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacology 1994;10:85-91.
6. Hohagen F, Fritsch Montero R, Weiss E, Lis S, et al. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 1994;244:65-72.
7. Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, et al. Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry 1994; 35:781-93.
8. Kupfer DJ, Spiker DG, Coble PA, Neil JF, et al. Sleep and treatment prediction in endogenous depression. Am J Psychiatry 1981;138:429-34.
9. Lian J. Nefazodone treatment of depression requires less use of concomitant anxiolytic and sedative/hypnotic drugs. APA New Research Program and Abstracts 1997;NR397:175.
10. Luthringer R, Toussaint M, Schaltenbrand N, Bailey P, et al. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull 1996;32:637-46.
11. Matheson GK, Knowles A, Guthrie D, Gage D, et al. Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat. Gen Pharmacol 1997;29:823-8.
12. Mitler MM, Nelson S, Hajdukovic R. Narcolepsy. Diagnosis, treatment, and management. Psychiatr Clin North Am 1987;10:593-606.
13. Nofzinger EA, Reynolds CF3, Thase ME, Frank E, et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 1995;152:274-6.
14. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: US Department of Health, Education & Welfare, Neurological Information Network, 1968.
15. Reynolds CF3, Kupfer DJ. Sleep research in affective illness: state of the art circa 1987. Sleep 1987;10:199-215.
16. Riemann D, Berger M. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 1990;81:24-31.
17. Ruigt GSF, Kemp B, Groenhout CM, Kamphuisen HA. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990;38:551-4.
18. Rush AJ, Armitage R, Gillin JC, Yonkers KA, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 1998;44: 3-14.
19. Sonntag A, Rothe B, Guldner J, Yassouridis A, et al. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 1996;4:1-13.
20. Steiger A, Benkert O, Wöhrmann S, Steinseifer D, et al. Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls. Neuropsychobiology 1989;21:71-5.
21. Steiger A, Gerken A, Benkert O, Holsboer F. Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls. Eur Neuropsychopharmacol 1993;3: 117-26.
22. Steiger A, Herth T, Holsboer F. Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. Acta Endocrinol (Copenh) 1987;116:36-42.
23. A-receptor modulation. Brain Res 1993;615:267-74.
24. Steiger A, von Bardeleben U, Guldner J, Lauer C, et al. The sleep EEG and nocturnal hormonal secretion. Studies on changes during the course of depression and on effects of CNS-active drugs. Prog Neuropsychopharmacol Biol Psychiatry 1993;17:125-37.
25. Steiger A, von Bardeleben U, Herth T, Holsboer F. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 1989;16: 189-95.
26. Vogel G, Cohen J, Mullis D, Kensler T, et al. Nefazodone and REM sleep - How do antidepressant drugs decrease REM sleep. Sleep 1998;21:70-7.
27. Vogel GW, Thurmond A, Gibbons P, Sloan K, et al. REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 1975;32:765-77.
28. Wiegand M, Berger M, Zulley J, von Zerssen D. The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 1986;19:198-9.